Toloxyloxacin dispersible tablet

【Drug name】

Chinese Mame:Toloxyloxacin dispersible tablet

Commodity Name:Hillford

English Name:Tosufloxacin Tosylate Dispersible Tablets

【Indications】

This product is applicable for the following infections induced by staphylococcus genus, streptococcus, pneumococcus (with penicillin resistant Streptococcus pneumoniae), enterococci, gonococcus, moraxella, escherichia coli, shigella dysenteriae, salmonella, typhoid bacillus, salmonella paratyphi, Citrobacter, Klebsiella, enterobacteriaceae, Serratia, Proteus species, Morganella morganii, Providencia, Vibrio cholerae, haemophilus influenzae, Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia (xanthomonas), acinetobacter, Peptostreptococcus, bacteroides, Prevotella loescheii, Propionibacterium acnes, etc. which are sensitive to tosufloxacin.
Superficial skin infections, deep skin infections, lymphangitis (lymphnoditis), chronic pyoderma, and acne (including acne pustulosa). Trauma, burn, secondary infection after surgery, mastitis, perianal abscess. Osteomyelitis, arthritis. Laryngitis, tonsillitis (peritonsillar abscess), acute bronchitis, pneumonia, secondary infection of chronic respiratory disease. Urocystitis, pyelonephritis, acute prostatitis, chronic prostatitis, epididymitis, urethritis. Cholecystitis, cholangitis. Bacillary dysentery, typhoid, paratyphoid, cholera. Bartholinitis, intrauterine infection, adnexitis. Dacryocystitis, hordeolum, meibomian gland. Otitis externa, otitis media, paranasal sinusitis, suppurative salivary adenitis. Periodontitis, pericoronitis, jaw inflammation.

【Specification】

0.15g (calculated as C26H23F3N4O6S)

【Validity】

36 months.

【Approval Number】

National Drug Standard H20100090

BG110-21-10-甲苯磺酸妥舒沙星分散片说明书-21-09-24.jpg